Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
Joon Young Hur(Hanyang University Guri Hospital), Kihyun Kım(State University of New York), Jin‐Oh Choi, Darae Kim(British Heart Foundation), Sang Eun Yoon(Sungkyunkwan University), Jung Eun Lee(Samsung Medical Center), Byungjun Kim(Severance Hospital), Jung‐Sun Kim(Yonsei University), Joon Young Choi(Samsung Medical Center), Seok Jin Kim(Samsung (South Korea)), Ju‐Hong Min(Samsung (South Korea)), Eun‐Seok Jeon
Cited by 1
Related Papers
Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA–PEG block copolymers
|Journal of Controlled Release|2003|793
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643